Archit Organosys Ltd
Fundamental Score
Archit Organosys Ltd Share Price Live NSE/BSE
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of ARCHITORG across key market metrics for learning purposes.
Positive Indicators
8 factors identified
Attractive Valuation (P/E: 12.51 vs Industry: 20.98)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity if fundamentals support the business case.
Robust Profit Growth (50.98%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture. This suggests positive business trajectory.
Excellent EPS Growth (44.16% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential and effective capital allocation over extended periods.
Strong Profit Growth Track Record (50.70% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model and effective operational leverage over time.
Strong Interest Coverage (5.07x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk and strong debt servicing capability.
Strong Cash Generation (₹50.23 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Balanced Promoter Holding (65.39%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment while ensuring adequate liquidity.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral, reducing forced-selling risk.
Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.
Risk Factors
2 factors identified
Below-Average Return on Equity (7.62%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Small Market Cap
Observation: Higher investment risk due to limited size.
Analysis: Small-cap stocks typically carry higher volatility and liquidity risks.
Financial Statements
Comprehensive financial data for Archit Organosys Ltd
About ARCHITORG
Business Overview
Archit Organosys Limited manufactures and trades in chemical products in India and internationally. The company offers monochloroacetic acid and sodium monochloroacetate that are used in the synthesis of various agricultural chemicals, cosmetic surfactants, oil drilling chemicals, plastic additives, etc. It also provides organic chemicals, pigments, and specialty derivatives, as well as adhesives and sealants under the AOL brand. The company was formerly known as Shri Chlochem Limited and changed its name to Archit Organosys Limited in May 2012. Archit Organosys Limited was founded in 1989 and is based in Ahmedabad, India.
Company Details
Key Leadership
Corporate Events
ARCHITORG Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of Archit Organosys Ltd (ARCHITORG)?
As of 11 Feb 2026, 10:11 am IST, Archit Organosys Ltd (ARCHITORG) is currently trading at ₹44.30. The stock has a market capitalization of ₹82.68 (Cr).
Is ARCHITORG share price Overvalued or Undervalued?
ARCHITORG is currently trading at a P/E ratio of 12.51x, compared to the industry average of 20.98x. Based on this relative valuation, the stock appears to be Undervalued against its sector peers.
What factors affect the Archit Organosys Ltd share price?
Key factors influencing ARCHITORG's price include its quarterly earnings growth (Sales Growth: 11.24%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Archit Organosys Ltd a good stock for long-term investment?
Archit Organosys Ltd shows a 5-year Profit Growth of 50.70% and an ROE of 7.62%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.39 before investing.
How does Archit Organosys Ltd compare with its industry peers?
Archit Organosys Ltd competes with major peers in the Commodity Chemicals. Investors should compare ARCHITORG's P/E of 12.51x and ROE of 7.62% against the industry averages to determine its competitive standing.
What is the P/E ratio of ARCHITORG and what does it mean?
ARCHITORG has a P/E ratio of 12.51x compared to the industry average of 20.98x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹13 for every ₹1 of annual earnings.
How is ARCHITORG performing according to Bull Run's analysis?
ARCHITORG has a Bull Run fundamental score of 63.1/100, which indicates moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.
What sector and industry does ARCHITORG belong to?
ARCHITORG operates in the Commodity Chemicals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Archit Organosys Ltd.
What is Return on Equity (ROE) and why is it important for ARCHITORG?
ARCHITORG has an ROE of 7.62%, which suggests challenges in generating returns from shareholders' equity. Return on Equity measures how efficiently Archit Organosys Ltd generates profits from shareholders' equity.
How is ARCHITORG's debt-to-equity ratio and what does it indicate?
ARCHITORG has a debt-to-equity ratio of 0.39, which indicates moderate leverage that should be monitored. A ratio below 1.0 generally indicates conservative financing.
What is ARCHITORG's dividend yield and is it a good dividend stock?
ARCHITORG offers a dividend yield of 1.24%, which means you receive ₹1.24 annual dividend for every ₹100 invested.
How has ARCHITORG grown over the past 5 years?
ARCHITORG has achieved 5-year growth rates of: Sales Growth 10.37%, Profit Growth 50.70%, and EPS Growth 44.16%.
What is the promoter holding in ARCHITORG and why does it matter?
Promoters hold 65.39% of ARCHITORG shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.
What is ARCHITORG's market capitalization category?
ARCHITORG has a market capitalization of ₹83 crores, placing it in the Small-cap category.
How volatile is ARCHITORG stock?
ARCHITORG has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is the 52-week high and low for ARCHITORG?
ARCHITORG has a 52-week high of ₹N/A and low of ₹N/A.
What is ARCHITORG's operating profit margin trend?
ARCHITORG has a 5-year average Operating Profit Margin (OPM) of 11.31%, indicating the company's operational efficiency.
How is ARCHITORG's quarterly performance?
Recent quarterly performance shows YoY Sales Growth of 11.24% and YoY Profit Growth of 50.98%.
What is the institutional holding pattern in ARCHITORG?
ARCHITORG has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the stock.